| 000 | 01028 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512211212.0 | ||
| 264 | 0 | _c19831220 | |
| 008 | 198312s 0 0 eng d | ||
| 022 | _a0378-584X | ||
| 024 | 7 |
_a10.1159/000215236 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWillemze, R | |
| 245 | 0 | 0 |
_aExperience with intermediate and high dose cytosine arabinoside in refractory acute leukaemia. _h[electronic resource] |
| 260 |
_bOnkologie _cAug 1983 |
||
| 300 |
_a200-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphoid _xdrug therapy |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aFibbe, W E | |
| 700 | 1 | _aZwaan, F E | |
| 773 | 0 |
_tOnkologie _gvol. 6 _gno. 4 _gp. 200-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000215236 _zAvailable from publisher's website |
| 999 |
_c6355868 _d6355868 |
||